Role for PP2A in ARF signaling to p53.

Activation of the ARF-p53 tumor suppressor pathway is one of the cell's major defense mechanisms against cancer induced by oncogenes. The ARF-p53 pathway is dysfunctional in a high proportion of human cancers. The regulation of the ARF-p53 signaling pathway has not yet been well characterized. In this study polyoma virus (Py) is used as a tool to better define the ARF-p53 signaling pathway. Py middle T-antigen (PyMT) induces ARF, which consequently up-regulates p53. We show that Py small T-antigen (PyST) blocks ARF-mediated activation of p53. This inhibition requires the small T-antigen PP2A-interacting domain. Our results reveal a previously unrecognized role of PP2A in the modulation of the ARF-p53 tumor suppressor pathway.

[1]  W. Hahn,et al.  Identification of specific PP2A complexes involved in human cell transformation. , 2004, Cancer cell.

[2]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[3]  U. Knippschild,et al.  Posttranslational modification of MDM2. , 2003, Molecular cancer research : MCR.

[4]  T. Hupp,et al.  Intrasteric regulation of MDM2. , 2003, Trends in biochemical sciences.

[5]  Huong T. T. Pham,et al.  Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution. , 2003, The Biochemical journal.

[6]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[7]  Robert A. Weinberg,et al.  Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation , 2002, Molecular and Cellular Biology.

[8]  C. Korgaonkar,et al.  ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization , 2002, Molecular and Cellular Biology.

[9]  S. Dilworth,et al.  Cell transformation by the middle T-antigen of polyoma virus , 2001, Oncogene.

[10]  Charles J. Sherr,et al.  The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.

[11]  M. Lomax,et al.  Polyoma virus disrupts ARF signaling to p53 , 2001, Oncogene.

[12]  G. Peters,et al.  Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus , 2001, Nature Cell Biology.

[13]  D. Woods,et al.  Regulation of p53 function. , 2001, Experimental cell research.

[14]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[15]  E. Sontag.  Protein phosphatase 2A: the Trojan Horse of cellular signaling. , 2001, Cellular signalling.

[16]  G. Muszyńska,et al.  Protein phosphatase 2A: variety of forms and diversity of functions. , 2001, Acta biochimica Polonica.

[17]  S. Zołnierowicz.  Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. , 2000, Biochemical pharmacology.

[18]  M. Fried,et al.  The p21WAF1/CIP1 Promoter Is Methylated in Rat-1 Cells: Stable Restoration of p53-Dependent p21WAF1/CIP1 Expression after Transfection of a Genomic Clone Containing the p21WAF1/CIP1 Gene , 2000, Molecular and Cellular Biology.

[19]  J. D. Weber,et al.  The ARF/p53 pathway. , 2000, Current opinion in genetics & development.

[20]  S. Dilworth,et al.  Association between src-kinases and the polyoma virus oncogene middle T-antigen requires PP2A and a specific sequence motif , 1999, Oncogene.

[21]  B. Hemmings,et al.  Regulation of protein kinase cascades by protein phosphatase 2A. , 1999, Trends in biochemical sciences.

[22]  R. DePinho,et al.  The INK4A/ARF locus and its two gene products. , 1999, Current opinion in genetics & development.

[23]  R. Honda,et al.  Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 , 1999, The EMBO journal.

[24]  F. Zindy,et al.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Ken Chen,et al.  The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.

[26]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[27]  A. Jochemsen,et al.  The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells , 1998, Oncogene.

[28]  O. Mor,et al.  p53 in polyoma virus transformed REF52 cells , 1997, Oncogene.

[29]  P. Branton,et al.  Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells , 1997, Journal of virology.

[30]  M. Mumby.  Regulation by tumour antigens defines a role for PP2A in signal transduction. , 1995, Seminars in cancer biology.

[31]  T. Roberts,et al.  Identification of regions in polyomavirus middle T and small t antigens important for association with protein phosphatase 2A , 1995, Journal of virology.

[32]  K. Sugasawa,et al.  Abrogation of p53-mediated transactivation by SV40 large T antigen. , 1993, Oncogene.

[33]  P. Robbins,et al.  SV40 T antigen abrogates p53-mediated transcriptional activity. , 1993, Oncogene.

[34]  P. Howley,et al.  The transcriptional transactivation function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein. , 1992, The EMBO journal.

[35]  K. Münger,et al.  Targeted degradation of the retinoblastoma protein by human papillomavirus E7‐E6 fusion proteins. , 1992, The EMBO journal.

[36]  A. Berk,et al.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein , 1992, Nature.

[37]  M. Scheffner,et al.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.

[38]  M. Mumby,et al.  Control of protein phosphatase 2A by simian virus 40 small-t antigen , 1991, Molecular and cellular biology.

[39]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[40]  S. Dilworth.  Cell alterations induced by the large T-antigens of SV40 and polyoma virus. , 1990, Seminars in cancer biology.

[41]  C. Slaughter,et al.  Association of protein phosphatase 2A with polyoma virus medium tumor antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. B. Miller,et al.  Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A , 1990, Cell.

[43]  T. Roberts,et al.  The cellular proteins which can associate specifically with polyomavirus middle T antigen in human 293 cells include the major human 70-kilodalton heat shock proteins , 1989, Journal of virology.

[44]  W. Welch,et al.  Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein , 1987, Journal of virology.

[45]  F. Cuzin.  The polyoma virus oncogenes. Coordinated functions of three distinct proteins in the transformation of rodent cells in culture. , 1984, Biochimica et biophysica acta.

[46]  G. Magnusson,et al.  T‐antigen expression by polyoma mutants with modified RNA splicing. , 1983, The EMBO journal.

[47]  N. Glaichenhaus,et al.  The roles of individual polyoma virus early proteins in oncogenic transformation , 1982, Nature.

[48]  A. Levine,et al.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.